ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.026,43
0,33%
S&P 500
5.221,18
-0,03%
US Dollar vs BRL
5,156
0,19%
Bitcoin
62.666,31
1,98%
Brent Oil
82,955
0,69%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. InVivo Therapeutics Holdings Corporation (NVIV)

  7. InVivo Therapeutics Holdings Corporation (NVIV) Notícias

NVIV

InVivo Therapeutics (NVIV)

InVivo Therapeutics Holdings Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVIV
DataHoraFonteTítuloCódigoCompanhia
21/03/202415:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202416:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202416:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202415:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/02/202410:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202310:35Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202310:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/11/202318:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/05/202317:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
25/04/202318:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202310:55Business WireInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/03/202318:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202208:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202219:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/11/202208:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/11/202219:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202217:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202217:01Business WireInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202212:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/10/202209:00Business WireInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/09/202209:00Business WireInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/09/202207:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
18/08/202210:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/08/202217:03Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
13/07/202209:30Business WireInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General CounselNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/07/202217:32Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/06/202209:30Business WireInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed NeurosurgeryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/06/202209:30Business WireInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury StudyNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/04/202217:30Business WireInVivo Therapeutics Announces Reverse Stock SplitNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVIV

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
COGN3
COGNA ON
BOV
VVEO3
CM Hospitalar ON
BOV
AZEV4
AZEVEDO PN
BOV
HAGA3
HAGA ON
BOV
LUPA3
LUPATECH ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
ETER3
ETERNIT ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AMAR3
LOJAS MARISA ON
BOV
PRIO3
PETRORIO ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
TECN3
TECHNOS ON
BOV
CASH3
Meliuz S.A ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados